drugset / Trial / NCT06962098
Efficacy and Safety Study of Isuzinaxib in Subjects With DKD
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study is a multicenter, double-blinded, randomized, placebo-controlled, dose-ranging study to evaluate the safety, tolerability, PK, and efficacy of Isuzinaxib compared with placebo in subjects with DKD.
Timeline
- Start
- 2025-05-26
- Primary completion
- 2027-06-30
- Completion
- 2028-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Isuzinaxib | Small molecule | 200 mg | Oral |
| Comparator | Isuzinaxib | Small molecule | 400 mg | Oral |